نتائج البحث - "Can Gönen"

1

Academic Journal

The Role of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Atrial Fibrillation: Treatment Management Based on Patient and Drug Characteristics

المؤلفون: Oktay Ergene, Dursun Aras, Cihangir Kaymaz, Ethem Murat Arsava, Can Gönen, Erdem Gürkaş, Uğur Arslan, Göksel Çağırıcı, Serkan Çay, Mustafa Kılıçkap, Selçuk Kanat, Ebru Özpelit, Fahriye Vatansever, Kadriye Kılıçkesmez

المصدر: Türk Kardiyoloji Derneği Arşivi, Vol 50, Iss 5, Pp 356-370 (2022)

مصطلحات موضوعية: Medicine, Internal medicine, RC31-1245, Diseases of the circulatory (Cardiovascular) system, RC666-701

Relation: https://archivestsc.com/en/the-role-of-non-vitamin-k-antagonist-oral-anticoagulants-noacs-in-atrial-fibrillation-treatment-management-based-on-patient-and-drug-characteristics-138270; https://doaj.org/toc/1016-5169; https://doaj.org/article/b407825fce464ca09147537c0faae66f

الاتاحة: https://doi.org/10.5543/tkda.2022.21191
https://doaj.org/article/b407825fce464ca09147537c0faae66f

View record in BASE

2

Vedolizumab versus Adalimumab for moderate-to-severe ulcerative colitis

المؤلفون: IVARS TOLMANIS, FABIANA CASTIGLIONE, Jingjing Chen, Vladimir Rafalskiy, Xavier Roblin, Can Gönen, Edward Loftus, Bruce Sands, Pavel Kohout, Silvio Danese, Ewa Malecka-Wojciesko, ENGIN ALTINTAS, Srdjan Djuranovic, Jaroslaw Regula, Laurent Peyrin-biroulet, Klaus Theede

المساهمون: Sands, B. E., Peyrin-Biroulet, L., Loftus, E. V., Danese, S., Colombel, J. -F., Toruner, M., Jonaitis, L., Abhyankar, B., Chen, J., Rogers, R., Lirio, R. A., Bornstein, J. D., Schreiber, S Varsity Study Group, Romano, M., RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Maag Darm Lever (9), Interne Geneeskunde, Icahn School of Medicine at Mount Sinai [New York] (MSSM), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Mayo Clinic [Rochester], Humanitas Clinical and Research Center [Rozzano, Milan, Italy], University Hospital Schleswig-Holstein [Kiel, Germany], Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S, Gionchetti P .., Sands, Be, Peyrin-Biroulet, L, Loftus, Ev, Danese, S, Colombel, Jf, Toruner, M, Jonaitis, L, Abhyankar, B, Chen, J, Rogers, R, Lirio, Ra, Bornstein, Jd, Schreiber, S

المصدر: New England Journal of Medicine, 381(13), 1215-1226. MASSACHUSETTS MEDICAL SOCIETY
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2019, 381 (13), pp.1215-1226. ⟨10.1056/NEJMoa1905725⟩

مصطلحات موضوعية: Male, [SDV]Life Sciences [q-bio], Anti-Inflammatory Agents, 030204 cardiovascular system & hematology, Adrenal Cortex Hormone, Inflammatory bowel disease, Gastroenterology, THERAPY, DISEASE, 0302 clinical medicine, Adrenal Cortex Hormones, 030212 general & internal medicine, Infusions, Intravenou, Infusions, Intravenous, ComputingMilieux_MISCELLANEOUS, Remission Induction, General Medicine, Orvostudományok, Middle Aged, Ulcerative colitis, 3. Good health, Anti-Inflammatory Agent, Drug Therapy, Combination, Female, medicine.drug, Human, Adult, medicine.medical_specialty, Ulcerative colitis, Vedolizumab, Adalimumab, Injections, Subcutaneous, Klinikai orvostudományok, Antibodies, Monoclonal, Humanized, Injections, Subcutaneou, Vedolizumab, 03 medical and health sciences, Pharmacotherapy, Double-Blind Method, Internal medicine, SCORE, medicine, Adalimumab, Humans, Colitis, ulcerative colitis, business.industry, Patient Acuity, medicine.disease, EFFICACY, digestive system diseases, Infliximab, Clinical trial, Colitis, Ulcerative, business